Icahn Enterprises L.P. Reports Fourth Quarter 2022 Financial Results
Icahn Enterprises reported a net loss of $183 million ($0.57 per unit) for the twelve months ending December 31, 2022, an improvement from $518 million in the prior year. Revenues increased to $14.1 billion from $11.3 billion in 2021. Adjusted EBITDA rose to $758 million compared to $273 million year-over-year. In Q4 2022, revenues were $3.1 billion with a net loss of $255 million. Despite a loss in Adjusted EBITDA of $54 million for the quarter, this marked an improvement from the previous year's loss of $443 million. The Indicative Net Asset Value grew by $522 million to $5.6 billion. The board declared a quarterly distribution of $2.00 per unit, continuing a consistent distribution trend since 2005.
- Revenues increased to $14.1 billion, up from $11.3 billion in 2021.
- Adjusted EBITDA improved to $758 million from $273 million year-over-year.
- Indicative Net Asset Value increased by $522 million to $5.6 billion.
- Net loss of $183 million compared to prior year's loss of $518 million.
- Fourth quarter net loss of $255 million indicates ongoing losses.
- Adjusted EBITDA loss of $54 million in Q4 2022, though improved from $443 million.
- For the twelve months ended
December 31, 2022 , net loss attributable toIcahn Enterprises was , or$183 million per depositary unit. For the twelve months ended$0.57 December 31, 2021 , net loss attributable toIcahn Enterprises was , or$518 million per depositary unit. For the twelve months ended$2.32 December 31, 2022 , Adjusted EBITDA attributable toIcahn Enterprises was compared to$758 million for the twelve months ended$273 million December 31, 2021 - Fourth quarter net loss attributable to IEP was
with Adjusted EBITDA loss attributable to IEP of$255 million . This is an improvement over prior year fourth quarter results of$54 million in net loss and$141 million Adjusted EBITDA$389 million - Indicative Net Asset Value increased by
to$522 million as of$5.6 billion December 31, 2022 compared toDecember 31, 2021 . The change in indicative net asset value includes, among other things, changes in the fair value of certain subsidiaries which are not included in our GAAP earnings - Board approves quarterly distribution of
per depositary unit (the 71st consecutive quarterly distribution since 2005)$2.00
Fourth quarter 2022 revenues were
For the twelve months ended
On
***
Caution Concerning Forward-Looking Statements
This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; risks related to the severity, magnitude and duration of the COVID-19 pandemic and its impact on the global economy, financial markets and industries in which our subsidiaries operate; the impacts from the
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||
(UNAUDITED) | ||||||||||||
Three Months Ended | Year Ended | |||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||
(in millions, except per unit amounts) | ||||||||||||
Revenues: | ||||||||||||
Net sales | $ | 3,280 | $ | 2,817 | $ | 13,378 | $ | 10,304 | ||||
Other revenues from operations | 186 | 161 | 748 | 647 | ||||||||
Net (loss) gain from investment activities | (478) | (842) | (168) | 193 | ||||||||
Interest and dividend income | 148 | 43 | 328 | 137 | ||||||||
(Loss) gain on disposition of assets, net | (11) | 165 | (8) | 141 | ||||||||
Other loss, net | (24) | (29) | (177) | (84) | ||||||||
3,101 | 2,315 | 14,101 | 11,338 | |||||||||
Expenses: | ||||||||||||
Cost of goods sold | 2,951 | 2,673 | 11,689 | 9,485 | ||||||||
Other expenses from operations | 142 | 141 | 583 | 522 | ||||||||
Selling, general and administrative | 329 | 308 | 1,250 | 1,238 | ||||||||
Restructuring, net | 2 | (1) | 2 | 5 | ||||||||
Interest expense | 144 | 155 | 568 | 666 | ||||||||
3,568 | 3,276 | 14,092 | 11,916 | |||||||||
(Loss) income before income tax benefit (expense) | (467) | (961) | 9 | (578) | ||||||||
Income tax benefit (expense) | 59 | 135 | (34) | 78 | ||||||||
Net loss | (408) | (826) | (25) | (500) | ||||||||
Less: net (loss) income attributable to non-controlling interests | (153) | (430) | 158 | 18 | ||||||||
Net loss attributable to | $ | (255) | $ | (396) | $ | (183) | $ | (518) | ||||
Net (loss) income attributable to | ||||||||||||
Limited partners | $ | (250) | $ | (484) | $ | (179) | $ | (604) | ||||
General partner | (5) | 88 | (4) | 86 | ||||||||
$ | (255) | $ | (396) | $ | (183) | $ | (518) | |||||
Basic and diluted loss per LP unit | $ | (0.74) | $ | (1.72) | $ | (0.57) | $ | (2.32) | ||||
Basic and diluted weighted average LP units outstanding | 340 | 281 | 316 | 260 | ||||||||
Distributions declared per LP unit | $ | 2.00 | $ | 2.00 | $ | 8.00 | $ | 8.00 |
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
(UNAUDITED) | ||||||
2022 | 2021 | |||||
(in millions) | ||||||
ASSETS | ||||||
Cash and cash equivalents | $ | 2,337 | $ | 2,321 | ||
Cash held at consolidated affiliated partnerships and restricted cash | 2,549 | 2,115 | ||||
Investments | 6,809 | 9,151 | ||||
Due from brokers | 7,044 | 5,530 | ||||
Accounts receivable, net | 606 | 546 | ||||
Inventories, net | 1,531 | 1,478 | ||||
Property, plant and equipment, net | 4,038 | 4,085 | ||||
Derivative assets, net | 812 | 612 | ||||
288 | 290 | |||||
Intangible assets, net | 533 | 595 | ||||
Other assets | 1,367 | 1,023 | ||||
Total Assets | $ | 27,914 | $ | 27,746 | ||
LIABILITIES AND EQUITY | ||||||
Accounts payable | $ | 870 | $ | 805 | ||
Accrued expenses and other liabilities | 1,981 | 1,778 | ||||
Deferred tax liabilities | 338 | 390 | ||||
Derivative liabilities, net | 691 | 787 | ||||
Securities sold, not yet purchased, at fair value | 6,495 | 5,340 | ||||
Due to brokers | 885 | 1,611 | ||||
Debt | 7,096 | 7,692 | ||||
Total liabilities | 18,356 | 18,403 | ||||
Equity: | ||||||
Limited partners | 4,647 | 4,298 | ||||
General partner | (747) | (754) | ||||
Equity attributable to | 3,900 | 3,544 | ||||
Equity attributable to non-controlling interests | 5,658 | 5,799 | ||||
Total equity | 9,558 | 9,343 | ||||
Total Liabilities and Equity | $ | 27,914 | $ | 27,746 |
Use of Non-GAAP Financial Measures
The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA and Adjusted EBITDA. EBITDA represents earnings from continuing operations before interest expense, income tax (benefit) expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA excluding certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. We present EBITDA and Adjusted EBITDA on a consolidated basis and on a basis attributable to
We believe that providing EBITDA and Adjusted EBITDA to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest, taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA and Adjusted EBITDA present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed.
EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in
- do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments;
- do not reflect changes in, or cash requirements for, our working capital needs; and
- do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt.
Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA and Adjusted EBITDA differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA and Adjusted EBITDA do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations.
EBITDA and Adjusted EBITDA are not measurements of our financial performance under
Use of Indicative Net Asset Value Data
The Company uses indicative net asset value as an additional method for considering the value of the Company's assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation.
The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management.
See below for more information on how we calculate the Company's indicative net asset value.
2022 | 2021 | ||
(in millions)(unaudited) | |||
Market-valued Subsidiaries and Investments: | |||
Holding Company interest in Investment Funds(1) | |||
CVR Energy(2) | 2,231 | 1,197 | |
Delek(2) | - | 105 | |
Total market-valued subsidiaries and investments | |||
Other Subsidiaries: | |||
| |||
| 455 | 472 | |
| 156 | 132 | |
Vivus(1) | 241 | 259 | |
Automotive Services(4) | 490 | 952 | |
Automotive Parts(1) | 381 | 422 | |
Automotive Owned Real Estate Assets(5) | 831 | 1,187 | |
| 1,702 | 2,561 | |
Total other subsidiaries | |||
Add: Other Holding Company net assets(6) | 20 | (3) | |
Indicative Gross Asset Value | |||
Add: Holding Company cash and cash equivalents(7) | 1,720 | 1,707 | |
Less: Holding Company debt(7) | (5,309) | (5,810) | |
Indicative Net Asset Value |
Indicative net asset value does not purport to reflect a valuation of IEP. The calculated indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, express or implied, is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary.
(1) | Represents GAAP equity attributable to us as of each respective date. |
(2) | Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by the Holding Company as of each respective date. |
(3) | Amounts based on market comparables due to lack of material trading volume, valued at 9.0x Adjusted EBITDA for the twelve months ended |
(4) | Amounts based on market comparables due to lack of material trading volume, valued at 14.0x Adjusted EBITDA for the twelve months ended |
(5) | Management performed a valuation on the owned real-estate with the assistance of third-party consultants to estimate fair-market-value. This analysis utilized property-level market rents, location level profitability, and utilized prevailing cap rates ranging from |
(6) | Holding Company's balance as of each respective date, excluding non-cash deferred tax assets or liabilities. |
(7) | Holding Company's balance as of each respective date. |
Three Months Ended | Year Ended | ||||||
2022 | 2021 | 2022 | 2021 | ||||
(in millions)(unaudited) | |||||||
Adjusted EBITDA | |||||||
Net loss | ( | ( | ( | ( | |||
Interest expense, net | 121 | 153 | 528 | 661 | |||
Income tax (benefit) expense | (59) | (135) | 34 | (78) | |||
Depreciation and amortization | 129 | 132 | 509 | 517 | |||
EBITDA before non-controlling interests | (217) | (676) | 1,046 | 600 | |||
Restructuring costs | 2 | 1 | 2 | 1 | |||
Loss (gain) on disposition of assets, net | 1 | (165) | (3) | (144) | |||
Transformation losses | 12 | 34 | 53 | 149 | |||
Net loss on extinguishment of debt | - | - | 1 | 5 | |||
Out of period adjustments | 52 | - | 52 | - | |||
Call option lawsuits settlement | - | - | 79 | - | |||
Other | 29 | 5 | 40 | 2 | |||
Adjusted EBITDA before non-controlling interests | ( | ( | |||||
Adjusted EBITDA attributable to IEP | |||||||
Net (loss) | ( | ( | ( | ( | |||
Interest expense, net | 87 | 114 | 393 | 480 | |||
Income tax (benefit) expense | (72) | (128) | (4) | (66) | |||
Depreciation and amortization | 90 | 92 | 352 | 367 | |||
EBITDA attributable to IEP | (150) | (318) | 558 | 263 | |||
Restructuring costs | 2 | 1 | 2 | 1 | |||
Loss (gain) on disposition of assets, net | 1 | (165) | (3) | (144) | |||
Transformation losses | 12 | 34 | 53 | 149 | |||
Net loss on extinguishment of debt | - | - | 1 | 3 | |||
Out of period adjustments | 52 | - | 52 | - | |||
Call option lawsuits settlement | - | - | 56 | - | |||
Other | 29 | 5 | 39 | 1 | |||
Adjusted EBITDA attributable to IEP | ( | ( |
Investor Contact:
(305) 422-4100
View original content:https://www.prnewswire.com/news-releases/icahn-enterprises-lp-reports-fourth-quarter-2022-financial-results-301755201.html
SOURCE
FAQ
What is Icahn Enterprises' net loss for 2022?
How did Icahn Enterprises perform in terms of revenue in 2022?
What is the quarterly distribution announced by Icahn Enterprises?
What was the Adjusted EBITDA for Icahn Enterprises in Q4 2022?